RadioGraphics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/rg.283055108
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Test (opens in a new window)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Hanna, R. F.
Right arrow Articles by Sirlin, C. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanna, R. F.
Right arrow Articles by Sirlin, C. B.
Related Collections
Right arrow Gastrointestinal Radiology
Right arrow Magnetic Resonance Imaging
RadioGraphics 2008;28:747-769
© RSNA, 2008


EDUCATION EXHIBIT

Cirrhosis-associated Hepatocellular Nodules: Correlation of Histopathologic and MR Imaging Features1

Robert F. Hanna, BS, Diego A. Aguirre, MD2, Norbert Kased, BS, Shawn C. Emery, MD, Michael R. Peterson, MD, PhD, and Claude B. Sirlin, MD

1 From the Department of Radiology, Division of Body Imaging (R.F.H., D.A.A., N.K., C.B.S.), and Department of Pathology (S.C.E., M.R.P.), University of California, San Diego, UCSD Liver Center, 200 W Arbor Dr, San Diego, CA 92103-8756. Recipient of a Certificate of Merit award for an education exhibit at the 2004 RSNA Annual Meeting. Received May 2, 2005; revision requested September 13; final revision received August 7, 2007; accepted August 21. The authors discuss an investigational or unlabeled use of a commercial product, device, or pharmaceutical that has not been approved for such purpose by the FDA. C.B.S. has received research grants from Bayer and General Electric; all remaining authors have no financial relationships to disclose. Address correspondence to C.B.S. (e-mail: csirlin{at}ucsd.edu).

Cirrhotic livers are characterized by advanced fibrosis and the formation of hepatocellular nodules, which are classified histologically as either (a) regenerative lesions (eg, regenerative nodules, lobar or segmental hyperplasia, focal nodular hyperplasia) or (b) dysplastic or neoplastic lesions (eg, dysplastic foci and nodules, hepatocellular carcinomas). The differentiation of these lesions is important because regenerative nodules are benign, whereas dysplastic and neoplastic nodules are premalignant and malignant, respectively. However, their accurate characterization may be difficult even at histopathologic analysis. Differential diagnosis may be facilitated by comparing the clinical and pathologic findings with radiologic imaging features; in particular, nodule size, vascularity, hepatocellular function, and Kupffer cell density assessed at magnetic resonance (MR) imaging are suggestive of the correct diagnosis. MR imaging is more useful than computed tomography for such assessments because it provides better soft-tissue contrast and a more nuanced depiction of different tissue properties. Moreover, a wider variety of contrast agents is available for use in MR imaging. Familiarity with the MR imaging characteristics of cirrhosis-associated hepatocellular nodules is therefore important for optimal diagnosis and management of cirrhotic disease.

© RSNA, 2008







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOGRAPHICS RADIOLOGY RSNA JOURNALS ONLINE
Copyright © 2008 by the Radiological Society of North America.